ULTRACLEAR

UltraClear, developed by Acclaro Medical, specializes in advanced skin rejuvenation laser technology.

It features the world's first 2910 nm cold ablative fractional fiber laser, designed to treat signs of aging across all skin types. The company focuses on innovative energy-based medical solutions for aesthetics, emphasizing precision, safety, and efficacy. Led by President Shlomo Assa, UltraClear boasts decades of expertise in medical devices and dermatologic research, holding over 50 patents. The flagship UltraClear® laser offers a range of treatments, from light peels to deep collagen remodeling, with minimal downtime and rapid healing. It effectively addresses fine lines, deep wrinkles, age spots, scars, uneven skin tone, and sun damage. The award-winning Laser-CoringTM therapy provides high-definition resurfacing and precise skin removal without the need for scalpels or stitches. Additionally, the AuraLuxTM fiber laser enhances aesthetic results and skin health. UltraClear continues to expand its capabilities, presenting new data and applications at industry events.